Valion Bio, Inc. (VBIO) Expects Entolimod Study Results in Early December

Valion expects top-line results in early December from an NIAID-funded animal efficacy study testing whether a single Entolimod dose 24 hours after radiation exposure improves survival in a GI-ARS model.Material DetailsContext by AI AnalystThis is an early-stage development update for Valion's lead…